| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |